The Role of Psychedelic Therapy in the Future of Psychotherapy
Live online September 25, 2020 10am-12pm Mountain Time
A live online lecture with Cathy Skipper and Florian Birkmayer MD
Psychedelic therapy can be considered one of the oldest forms of therapy for soul healing and at the same time is now considered cutting edge in biomedical medicine after decades of being shunned. After a period of promising research in the 50’s and early 60’s, the recreational use of psychedelics spread far and wide, the healing intentions and sacred focus were widely forgotten or obscured by sensationalist news stories and there was a widespread backlash. Their healing promise and the sacred tradition, along with the accumulated wisdom, was mostly forgotten. Over the last 25 years, there has been a renaissance of official, academic research into psychedelic therapy, mostly focusing on psilocybin, MDMA, LSD and ketamine. Some substances such as LSD, MDMA, psilocybin, remain illegal except in controlled research studies, but others such as ketamine are being used to great effect for depression, PTSD and a range of other indications.
Join Florian Birkmayer, MD and Cathy Skipper for a discussion of the role of psychedelics in the future of psychotherapy. What should psychotherapists know about these treatment options? What types of clients are good candidates and how can psychotherapists work with and support clients who are interested in this form of therapy?
This live online presentation will take place on September 25, 2020 from 10am to 12pm Mountain Time via the Zoom app.
CEUs are available.
Here’s how to register:
- Click on the ‘Sign me up’ button and enter the information requested.
- After you registered, you will automatically receive an email with details of the live online lecture.
- A few days before the presentation we will email you a link for the zoom meeting, including a link to download zoom if you need.
If you still have questions, please get in touch at email@example.com we will be happy to help.
(+1) 505 362 2385